SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019540
Filing Date
2021-08-12
Accepted
2021-08-12 07:33:37
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 bcda-20210630.htm   iXBRL 10-Q 750486
2 ex_272097.htm EX-31.1 11203
3 ex_272098.htm EX-31.2 10984
4 ex_272099.htm EX-32.1 4361
5 ex_272100.htm EX-32.2 4378
  Complete submission text file 0001437749-21-019540.txt   3956782

Data Files

Seq Description Document Type Size
6 bcda-20210630.xsd EX-101.SCH 44651
7 bcda-20210630_cal.xml EX-101.CAL 30966
8 bcda-20210630_def.xml EX-101.DEF 256977
9 bcda-20210630_pre.xml EX-101.PRE 285404
10 bcda-20210630_lab.xml EX-101.LAB 252291
11 EXTRACTED XBRL INSTANCE DOCUMENT bcda-20210630_htm.xml XML 572796
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 211165505
SIC: 2836 Biological Products, (No Diagnostic Substances)